Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Celebrex “Black Box” Label Warning About Increased Cardiovascular Risks
"Class Effect": Like Bextra and Vioxx, Celebrex Can Cause Heart Attacks and Strokes The pharmaceutical company Pfizer Inc. announced on August 1, 2005 that the FDA had finalized a new label for the arthritis…
-
All NSAIDs May Be Linked to Increased Risk of Heart Attack (or Not)
June 2005 BMJ Article Calls Into Doubt Cardiovascular Safety of All NSAIDs There is new evidence that all selective and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with an increased risk of having a…
-
Case Report: Adderall-induced Heart Attack in Young Boy
Reports of Sudden Unexplained Death (SUD) Involving Children Being Studied by FDA After Adderall Withdrawn in Canada An article entitled "Myocardial infarction in an adolescent taking Adderall", by Pritesh J. Gandhi, et.al., was published…
-
Recent Study Shows How Vioxx, Bextra, and Celebrex Can Damage Heart
A Theory of Why COX-2 Inhibitors Affect the Heart and Raise Heart Attack Risk In May 2005 it was reported that medical researchers affiliated with the University of Pennsylvania School of Medicine have…
-
Health Canada Advisory Panel Supports Return of Painkiller Vioxx to Market
Canadian Panel Votes Against Bextra Due to Increased Risk of Serious Skin Reactions On July 7, 2005, a panel of medical experts advised Health Canada officials that, in its opinion, the arthritis drug and…
-
Novantrone: FDA MedWatch Alert Regarding Heart Damage Risks
April 2005 "Dear Doctor" Letter Also Addressed an Increased Risk of AML In late May 2005 the FDA warned patients of the risk of heart damage from Serono’s multiple sclerosis drug Novantrone. In a…
-
European Drug Regulators Want Increased Warnings on All COX-2 Inhibitor Drugs
Bextra: Suspension of Marketing in European Union to Continue In a June 27, 2005 press release issued by the European Medicines Agency (EMEA), the Agency’s Committee for Medicinal Products for Human Use (CHMP) said…
-
Black-box Warning for Celebrex and Other NSAIDs
FDA Requires Warning Label Changes for Painkillers In June 2005 the FDA advised Pfizer, the maker of Celebrex, and several other drug manufacturers that the package insert, or warning label, for their prescription NSAID…
-
Sudden Cardiac Death Caused by Some Commonly Prescribed Drugs
Increased Risk of Sudden Death Linked to Use of Some Widely Used Medications A study which analyzed 775 cases of sudden cardiac deaths in the Netherlands has found some commonly prescribed drugs may interfere…